501097-31-0

Basic information

• Product Name: Glycine, N-[(1,1-dimethylethoxy)carbonyl]-N-[3-[[(1,1-dimethylethoxy)carbonyl][3- [[(4-methoxyphenyl)diphenylmethyl]amino]propyl]amino]propyl]-, 1,1-dimethylethyl ester
• CAS NO: 501097-31-0
• Molecular Formula: C42H59N3O7
• Molecular Weight: 717.946
• Mol File: 501097-31-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Glycine, N-[(1,1-dimethylethoxy)carbonyl]-N-[3-[[(1,1-dimethylethoxy)carbonyl][3- [[(4-methoxyphenyl)diphenylmethyl]amino]propyl]amino]propyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Glycine, N-[(1,1-dimethylethoxy)carbonyl]-N-[3-[[(1,1-dimethylethoxy)carbonyl][3- [[(4-methoxyphenyl)diphenylmethyl]amino]propyl]amino]propyl]-, 1,1-dimethylethyl ester(501097-31-0)
• EPA Substance Registry System: Glycine, N-[(1,1-dimethylethoxy)carbonyl]-N-[3-[[(1,1-dimethylethoxy)carbonyl][3- [[(4-methoxyphenyl)diphenylmethyl]amino]propyl]amino]propyl]-, 1,1-dimethylethyl ester(501097-31-0)

Safety Data

• Hazardous Substances Data: 501097-31-0(Hazardous Substances Data)

Upstream product

• 501097-30-9 (tert-butoxycarbonyl-{3-[(3-{[(4-methoxy-phenyl)-diphenyl-methyl]-amino}-propyl)-(2-nitro-benzenesulfonyl)-amino]-propyl}-amino)-acetic acid tert-butyl ester 
• 501097-29-6 {tert-butoxycarbonyl-[3-(2-nitro-benzenesulfonylamino)-propyl]-amino}-acetic acid tert-butyl ester 
• 14470-28-1 mono-4-methoxytrityl chloride 
• 501097-15-0 N-(4-monomethoxytrityl)-3-bromopropylamine 
• 24424-99-5 di-tert-butyl dicarbonate 

Relevant articles and documents

Modelling, synthesis and biological evaluation of an ethidium-arginine conjugate linked to a ribonuclease mimic directed against TAR RNA of HIV-1

Using molecular modelling studies, an active anti-HIV ethidium-arginine conjugate targeted against the viral TAR RNA sequence has been linked to an artificial ribonuclease, with the aim to obtain an irreversible inhibitor. The ribonuclease moiety consists of an N-[N-(3-aminopropyl)-3-aminopropyl] glycine and has been constructed via two successive N-alkylations following the Fukuyama procedure.